Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cβ1

Abnormal phospholipid metabolism has been implicated in the pathogenesis of schizophrenia, and it was reported that phospholipase C (PLC) β1 is reduced in specific brain areas of patients with schizophrenia. However, the causal relationship of the PLCβ1 gene with behavioral symptoms of schizophrenia remains unclear. To address this issue, we have examined the mutant mice lacking PLCβ1 for schizophrenia‐related phenotypes by performing various behavioral tests, including general locomotor activity, sensorimotor gating, social behaviors, and learning and memory. Phospholipase C β1 knockout mice showed hyperactivities in an open field. They showed impaired prepulse inhibition of acoustic startle response, which was ameliorated by a systemic administration of an antipsychotic D2‐receptor antagonist, haloperidol. In addition, they showed abnormal social behaviors, such as lack of barbering behavior, socially recessive trait and lack of nesting behavior. Furthermore, they showed impaired performance in the delayed‐non‐match‐to‐sample T‐maze test. The present results show that the PLCβ1 mutant mice share some of the behavioral abnormalities that have been reported in patients with schizophrenia. Thus, the PLCβ1‐linked signaling pathways may be involved in the neural system whose function is disrupted in the pathogenesis of schizophrenia.

[1]  James M. Stone,et al.  Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review , 2007, Journal of psychopharmacology.

[2]  K. Jakobs,et al.  Dynamic phospholipid signaling by G protein-coupled receptors. , 2007, Biochimica et biophysica acta.

[3]  B. Turetsky,et al.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. , 2006, Schizophrenia bulletin.

[4]  J. Gogos,et al.  Modeling Madness in Mice: One Piece at a Time , 2006, Neuron.

[5]  Gregory A. Miller,et al.  Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia , 2006, Schizophrenia Research.

[6]  S. Ryu,et al.  Haloperidol induces calcium ion influx via L-type calcium channels in hippocampal HN33 cells and renders the neurons more susceptible to oxidative stress. , 2006, Molecules and cells.

[7]  T. Miyakawa,et al.  Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? , 2006, Biological Psychiatry.

[8]  G. Robertson,et al.  Schizophrenia: an integrative approach to modelling a complex disorder. , 2006, Journal of psychiatry & neuroscience : JPN.

[9]  M. Covic,et al.  Arginine Methylation Regulates DNA Polymerase β , 2006 .

[10]  A. Epstein,et al.  Knocking‐down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning , 2006, Journal of neurochemistry.

[11]  J. Gogos,et al.  Schizophrenia susceptibility genes: emergence of positional candidates and future directions. , 2006, Trends in pharmacological sciences.

[12]  I. Gottesman,et al.  Psychiatric endophenotypes and the development of valid animal models , 2006, Genes, brain, and behavior.

[13]  E. Kandel,et al.  Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.

[14]  Hee-Sup Shin,et al.  Genetic dissection of theta rhythm heterogeneity in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Naoshi Kaneko,et al.  Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. , 2005, American journal of human genetics.

[16]  R. Malenka,et al.  A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Fradley,et al.  STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating , 2005, Behavioural Brain Research.

[18]  M. Suaud-Chagny,et al.  Dopaminergic transmission in STOP null mice , 2005, Journal of neurochemistry.

[19]  Xu-Feng Huang,et al.  Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  J. Crawley Designing mouse behavioral tasks relevant to autistic-like behaviors. , 2004, Mental retardation and developmental disabilities research reviews.

[21]  J. Feldon,et al.  Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment , 2004, Psychopharmacology.

[22]  R. Paylor,et al.  Expanded characterization of the social interaction abnormalities in mice lacking Dvl1 , 2004, Genes, Brain and Behavior.

[23]  Hongkui Zeng,et al.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Paul Antoine Salin,et al.  The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. , 2002, Genes & development.

[25]  A. Martelli,et al.  Molecular characterization of the human PLC β1 gene , 2002 .

[26]  T. Sotnikova,et al.  Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Hongkui Zeng,et al.  Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.

[28]  A Carlsson,et al.  A Paradigm Shift in Brain Research , 2001, Science.

[29]  R. Gainetdinov,et al.  Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.

[30]  R. Wong,et al.  Group I Metabotropic Glutamate Receptors Elicit Epileptiform Discharges in the Hippocampus through PLCβ1 Signaling , 2001, Journal of Neuroscience.

[31]  Noboru Kitamura,et al.  Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  D. Kupfer,et al.  Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria , 2001, Biological Psychiatry.

[33]  R. Dias,et al.  Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching‐ and matching‐to‐place in the T‐maze in the rat: differential involvement of the prelimbic–infralimbic and anterior cingulate cortices in providing behavioural flexibility , 2000, The European journal of neuroscience.

[34]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[35]  Y. Smith,et al.  Anatomy of the dopamine system in the basal ganglia , 2000, Trends in Neurosciences.

[36]  A. Hamm,et al.  Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients , 2000, Biological Psychiatry.

[37]  O. Shirakawa,et al.  Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia , 1999, Biological Psychiatry.

[38]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[39]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[40]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[41]  Masahiko Watanabe,et al.  Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cβ in mouse brain , 1998, The European journal of neuroscience.

[42]  S. Ryu,et al.  Phospholipase C isozymes selectively couple to specific neurotransmitter receptors , 1997, Nature.

[43]  Richard Paylor,et al.  Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.

[44]  S. Rhee,et al.  Regulation of Phosphoinositide-specific Phospholipase C Isozymes* , 1997, The Journal of Biological Chemistry.

[45]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Andreasen,et al.  Symptoms, signs, and diagnosis of schizophrenia , 1995, The Lancet.

[47]  A. A. Spector,et al.  Membrane lipid composition and cellular function. , 1985, Journal of lipid research.

[48]  M. Festing,et al.  Whisker trimming in mice , 1981, Laboratory animals.

[49]  A. Oliverio,et al.  Dominance behavior: A phylogenetic analysis in the mouse , 1975, Physiology & Behavior.

[50]  S. Iversen,et al.  The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.

[51]  C. W. Schneider,et al.  Effects of Hallucinogenic and other Drugs on the Nest-building Behaviour of Mice , 1970, Nature.

[52]  B. Garner,et al.  Importance of animal models in schizophrenia research. , 2005, The Australian and New Zealand journal of psychiatry.

[53]  A. Martelli,et al.  Molecular characterization of the human PLC beta1 gene. , 2002, Biochimica et biophysica acta.

[54]  D. Braff,et al.  51 ENDOPHENOTYPES IN STUDIES OF THE GENETICS OF SCHIZOPHRENIA , 2002 .

[55]  T. Goldberg,et al.  Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.

[56]  G. Pascal,et al.  Essentiality of omega 3 fatty acids for brain structure and function. , 1991, World review of nutrition and dietetics.

[57]  G. Pascal,et al.  Essentiality of ω3 Fatty Acids for Brain Structure and Function1 , 1991 .